Longboard Pharmaceuticals Inc’s recently made public that its Former 10% Owner ARENA PHARMACEUTICALS INC unloaded Company’s shares for reported $96.48 million on Jan 25 ’24. In the deal valued at $24.25 per share,3,978,540 shares were sold. As a result of this transaction, ARENA PHARMACEUTICALS INC now holds 0 shares worth roughly $0.0.
Citigroup initiated its Longboard Pharmaceuticals Inc [LBPH] rating to a Buy in a research note published on February 16, 2024; the price target was $40. B. Riley Securities began covering LBPH with “Buy” recommendation on April 27, 2023. Evercore ISI started covering the stock on April 07, 2021. It rated LBPH as “an Outperform”.
Price Performance Review of LBPH
On Tuesday, Longboard Pharmaceuticals Inc [NASDAQ:LBPH] saw its stock unchanged to $18.25. Over the last five days, the stock has lost -1.78%. Longboard Pharmaceuticals Inc shares have risen nearly 202.65% since the year began. Nevertheless, the stocks have risen 200.16% over the past one year. While a 52-week high of $28.15 was reached on 01/23/24, a 52-week low of $3.60 was recorded on 01/02/24. SMA at 50 days reached $20.25, while 200 days put it at $11.42. A total of 0.28 million shares were traded, compared to the trading of 0.55 million shares in the previous session.
Levels Of Support And Resistance For LBPH Stock
The 24-hour chart illustrates a support level at 17.95, which if violated will result in even more drops to 17.64. On the upside, there is a resistance level at 18.58. A further resistance level may holdings at 18.90. The Relative Strength Index (RSI) on the 14-day chart is 43.05, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.67, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.24%. Stochastics %K at 18.50% indicates the stock is a buying.
The most recent change occurred on April 06, 2021 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $27 price target.
